Literature DB >> 10435605

Prefrontal dysfunction and treatment response in geriatric depression.

B Kalayam1, G S Alexopoulos.   

Abstract

BACKGROUND: This study investigated the relationship of clinical, neuropsychological, and electrophysiological measures of prefrontal dysfunction with treatment response in elderly patients with major depression.
METHODS: Forty-nine depressed elderly subjects were studied before and after 6 weeks of adequate antidepressant treatment and compared with 22 psychiatrically normal controls. The psychomotor retardation item of the Hamilton Depression Rating Scale, the initiation/perseveration subscore of the Mattis Dementia Rating Scale, and the latency of the P300 auditory evoked potential were used as indices of prefrontal dysfunction. The intensity of antidepressant drug treatment was classified and monitored for a 6-week period.
RESULTS: Abnormal initiation/perseveration score, psychomotor retardation, and long P300 latency predicted 58% of the variance in change of depression scores from baseline to 6 weeks (F3= 20.1, P<.001). Depressed patients who remained symptomatic (n = 25) had more abnormal initiation/perseveration scores and longer P300 latency compared with depressed patients who achieved remission (n = 24) and control subjects. There were no differences between the last 2 groups. The association between psychomotor retardation, initiation/perseveration scores, P300 latency, and response to antidepressant treatment could not be explained by differences in demographic and clinical characteristics or treatment intensity between remitted and nonremitted depressed patients.
CONCLUSIONS: Prefrontal dysfunction was associated with poor or delayed antidepressant response in depressed elderly patients. This observation, if confirmed, may aid clinicians in identifying candidates for aggressive somatic therapies and for interventions offering structure of daily activities.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10435605     DOI: 10.1001/archpsyc.56.8.713

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  62 in total

Review 1.  A Meta-Analysis of Executive Dysfunction and Antidepressant Treatment Response in Late-Life Depression.

Authors:  Monique A Pimontel; David Rindskopf; Bret R Rutherford; Patrick J Brown; Steven P Roose; Joel R Sneed
Journal:  Am J Geriatr Psychiatry       Date:  2015-05-21       Impact factor: 4.105

Review 2.  Mood, cognition and in vivo protein imaging: the emerging nexus in clinical neuroscience.

Authors:  Anand Kumar; Olusola Ajilore; Vladimir Kepe; Jorge R Barrio; Gary Small
Journal:  Int J Geriatr Psychiatry       Date:  2008-06       Impact factor: 3.485

3.  Neurocognitive correlates of response to treatment in late-life depression.

Authors:  Tyler J Story; Guy G Potter; Deborah K Attix; Kathleen A Welsh-Bohmer; David C Steffens
Journal:  Am J Geriatr Psychiatry       Date:  2008-08-12       Impact factor: 4.105

Review 4.  [Executive functions in patients with depression. The role of prefrontal activation].

Authors:  N Vasic; R C Wolf; H Walter
Journal:  Nervenarzt       Date:  2007-06       Impact factor: 1.214

5.  Functional connectivity in the cognitive control network and the default mode network in late-life depression.

Authors:  George S Alexopoulos; Matthew J Hoptman; Dora Kanellopoulos; Christopher F Murphy; Kelvin O Lim; Faith M Gunning
Journal:  J Affect Disord       Date:  2012-03-15       Impact factor: 4.839

Review 6.  The vascular depression hypothesis: mechanisms linking vascular disease with depression.

Authors:  W D Taylor; H J Aizenstein; G S Alexopoulos
Journal:  Mol Psychiatry       Date:  2013-02-26       Impact factor: 15.992

7.  Auditory P3 in antidepressant pharmacotherapy treatment responders, non-responders and controls.

Authors:  Natalia Jaworska; Elisea De Somma; Claude Blondeau; Pierre Tessier; Sandhaya Norris; Wendy Fusee; Dylan Smith; Pierre Blier; Verner Knott
Journal:  Eur Neuropsychopharmacol       Date:  2013-05-09       Impact factor: 4.600

8.  Transdermal Nicotine for the Treatment of Mood and Cognitive Symptoms in Nonsmokers With Late-Life Depression.

Authors:  Jason A Gandelman; Hakmook Kang; Ashleigh Antal; Kimberly Albert; Brian D Boyd; Alexander C Conley; Paul Newhouse; Warren D Taylor
Journal:  J Clin Psychiatry       Date:  2018-08-28       Impact factor: 4.384

9.  Elevation in plasma Abeta42 in geriatric depression: a pilot study.

Authors:  Nunzio Pomara; P Murali Doraiswamy; Lisa M Willoughby; Amy E Roth; Benoit H Mulsant; John J Sidtis; Pankaj D Mehta; Charles F Reynolds; Bruce G Pollock
Journal:  Neurochem Res       Date:  2006-04-01       Impact factor: 3.996

10.  Preliminary analysis of age of illness onset effects on symptom profiles in major depressive disorder.

Authors:  Rebecca A Charlton; Melissa Lamar; Olusola Ajilore; Anand Kumar
Journal:  Int J Geriatr Psychiatry       Date:  2013-02-19       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.